[HTML][HTML] Drug resistance and combating drug resistance in cancer

X Wang, H Zhang, X Chen - Cancer drug resistance, 2019 - ncbi.nlm.nih.gov
Cancer is the second leading cause of death in the US. Current major treatments for cancer
management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy …

Purinergic signalling and disorders of the central nervous system

G Burnstock - Nature reviews Drug discovery, 2008 - nature.com
Purines have key roles in neurotransmission and neuromodulation, with their effects being
mediated by the purine and pyrimidine receptor subfamilies, P1, P2X and P2Y. Recently …

Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

P Pellegatti, L Raffaghello, G Bianchi, F Piccardi… - PloS one, 2008 - journals.plos.org
Background There is growing awareness that tumour cells build up a “self-advantageous”
microenvironment that reduces effectiveness of anti-tumour immune response. While many …

Purines, purinergic receptors, and cancer

F Di Virgilio - Cancer research, 2012 - AACR
Purines were long thought to be restricted to the intracellular compartment, where they are
used for energy transactions, nucleic acid synthesis, and a multiplicity of biochemical …

Purinergic signalling and cancer

G Burnstock, F Di Virgilio - Purinergic signalling, 2013 - Springer
Receptors for extracellular nucleotides are widely expressed by mammalian cells. They
mediate a large array of responses ranging from growth stimulation to apoptosis, from …

Glioblastoma hijacks microglial gene expression to support tumor growth

SLN Maas, ER Abels, LL Van De Haar, X Zhang… - Journal of …, 2020 - Springer
Background Glioblastomas are the most common and lethal primary brain tumors. Microglia,
the resident immune cells of the brain, survey their environment and respond to pathogens …

Pathophysiology of astroglial purinergic signalling

H Franke, A Verkhratsky, G Burnstock, P Illes - Purinergic signalling, 2012 - Springer
Astrocytes are fundamental for central nervous system (CNS) physiology and are the fulcrum
of neurological diseases. Astroglial cells control development of the nervous system …

Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell …

SFM Häusler, I Montalbán del Barrio… - Cancer Immunology …, 2011 - Springer
The ectonucleotidases CD39 and CD73 degrade immune stimulatory ATP to adenosine that
inhibits T and NK cell responses via the A 2A adenosine receptor (ADORA2A). This …

The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma

A Zanotto-Filho, E Braganhol, MI Edelweiss… - The Journal of nutritional …, 2012 - Elsevier
Previous studies suggested that curcumin is a potential agent against glioblastomas
(GBMs). However, the in vivo efficacy of curcumin in gliomas remains not established. In this …

CD73 downregulation decreases in vitro and in vivo glioblastoma growth

JH Azambuja, NE Gelsleichter, LR Beckenkamp… - Molecular …, 2019 - Springer
Glioblastoma is the worst and most common primary brain tumor. Here, we demonstrated
the role of CD73, an enzyme responsible for adenosine (ADO) production, in glioblastoma …